MLB: Brewers RHP J.B. Bukauskas to miss time with lat injury

Date:

Share post:


Milwaukee Brewers right-hander J.B. Bukauskas will miss an undetermined amount of time with a lat injury.

Bukauskas, a former first-round draft pick by the Houston Astros in 2017, is deciding between rehab and surgery for an injury that happened during a throwing session last week.

It is yet another in a series of injuries for the formerly highly regarded 28-year-old pitcher, who has made 33 major league appearances with three different clubs. Bukauskas also has dealt with a torn teres major muscle, a cervical strain and a previous lat injury in April of last year.

Bukauskas had a 1.50 ERA in six relief appearances with the Brewers last season. He is 2-2 with a 5.04 ERA in his 33 relief appearances for the Arizona Diamondbacks (2021), Seattle Mariners (2023) and Brewers.

The Brewers also signed veteran outfielder Manual Margot to a minor league contract, according to multiple reports. Margot was added after outfielder Blake Perkins fractured his right shin on a foul ball during batting practice last week.

Margot, 30, is a career .254 hitter with 56 home runs and 314 RBIs in 917 games for the San Diego Padres (2016-19), Tampa Bay Rays (2020-23) and Minnesota Twins (2024).

–Field Level Media

spot_img

Related articles

NCAABBL: MCWS: Kade Anderson’s gem lifts LSU over Arkansas

Kade Anderson allowed just three hits and one run in seven innings and No. 6 national seed LSU...

NCAABBL: MWCS: UCLA leverages pivotal fourth inning in win over Murray State

AJ Salgado's two-run double capped a four-run fourth inning to give No. 15 UCLA the cushion it needed...

MLB: Astros rally in ninth, sweep Twins with walk-off in tenth

Mauricio Dubon hit a walk-off single to left field with two outs in the 10th inning, and the...

MLB: Braxton Fulford drives in five as Rockies smash Braves

Braxton Fulford drove in a career-best five runs and Austin Gomber threw five scoreless innings in his season...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.